Figure 1 Collagen is associated with ChemR23 expression in human and murine vascular smooth muscle cells. (A) Positive ... Figure 1 Collagen is associated.

Slides:

Advertisements

Similar presentations

Arginase I enhances vascular smooth muscle cell proliferation by increasing intracellular polyamine production (A and B) Arginase I enhances cell proliferation.

Advertisements

Unless provided in the caption above, the following copyright applies to the content of this slide: © 2019 European Society of Cardiology and British Pharmacological.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Figure 1 Data-selection process

Figure 1 Flow diagram detailing the systematic review process.

Figure 1 Multivariable-adjusted predictors of PAC

Figure 1 Schematic representation of the experimental design.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Figure 1 Unadjusted Kaplan–Meier curves for all-cause mortality in the transcatheter mitral valve repair and ... Figure 1 Unadjusted Kaplan–Meier curves.

Figure 1 Mechanism of mortality benefit associated with radial access

Fig. 1 Bone scintigraphy of the right tibia of the patient at disease onset (A), after 10 years of calcitonin ... Fig. 1 Bone scintigraphy of the right.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Figure 1 The Kaplan–Meier curves of time to death post first hospitalization. hosp, hospitalization. Unless provided in the caption above, the following.

AHA: American Heart Association; ALT: ...

Figure 1. Serum ceftazidime concentrations following intravenous administration. Unless provided in the caption above, the following copyright applies.

Figure 1 A dot plot illustrating the correlation between the yearly absolute risk difference for both MACE and major ... Figure 1 A dot plot illustrating.

Fig. 1 CT demonstrating aortic wall thickening with renal artery involvement (short arrow). There is also subtle ... Fig. 1 CT demonstrating aortic wall.

Source: Figure created by the author based on data ...

(A) Upper ... (A) Upper gastroduodenoscopy showing gastric antral vascular ectasia with visible bleeding. (B) Nailfold capillaroscopy showing dilated capillaries.

Black: diagnosis ... Black: diagnosis from any department; grey: diagnosis at a rheumatology department. Unless provided in the caption above, the following.

Fig. 1 Graphical representation of improving mortality in stroke patients since the inception of a national stroke ... “Graph courtesy of George Dunn,

Fig. 1 MRI aspect of an osteitis of the left acetabulum at baseline (A), 3 months (B), 1 year (C) and 2 years later, ... Fig. 1 MRI aspect of an osteitis.

Take home figure The protective role of CNP/NPR-B/NPRC.

Fig. 3 Interrelationship between themes describing the experiences of people with shoulder disorders Unless provided in the caption above, the following.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

x-axis, post-partum days. Closed ...

Fig. 1. A flowchart of cohort participants screened, enrolled and followed-up between 1 July 2015 and 31 May Fig. 1. A flowchart of cohort participants.

Figure 1 Representative examples of three-dimensional volume-rendered CT images of AOLCA (A) and AORCA (B) with an IAC ... Figure 1 Representative examples.

Fig. 1 Subacute cutaneous lupus erythematous at the lower limbs

Fig. 1 Flow chart of included patients for analyses

Rats were treated for 21 days ...

Fig. 1 Flow chart for selection of study subjects

Prevalence and distribution of ...

Figure 1 Selection algorithm of patients being included in the German Aortic Valve Registry in 2014 and Figure 1 Selection algorithm of patients.

Figure 1 Cumulative late adjusted survival in cardiac resynchronization therapy defibrillator and pacemaker patients. ... Figure 1 Cumulative late adjusted.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Figure 1 Relationships between pair indices of dance performance (joint entropy or mutual information) and the past ... Figure 1 Relationships between.

Figure 1. Flow diagram for selection of articles for systematic review. Unless provided in the caption above, the following copyright applies to the content.

Figure 1. Time–kill studies for selected isolates (each line represents the average of duplicate studies). AMP, ... Figure 1. Time–kill studies for selected.

Figure 1 Immunohistochemistry for human cell differentiation molecules in samples of the right ventricular septum from ... Figure 1 Immunohistochemistry.

Figure 1. Percentage of Pacific and European children completing all components of B4SC in 2013 and 2015 Figure 1. Percentage of Pacific and European.

Figure 1 MIC test strips showing reversion of daptomycin resistance of isolate 5 passaged in vitro. This figure ... Figure 1 MIC test strips showing reversion.

Figure Ranking of Cardiovascular Journals as published by Clarivate Analytics. Unless provided in the caption above, the following copyright applies.

Figure 1. Trunk and leg fat over study period. LS, log transformed.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Figure 1. Data access using HMP16SData

Take home figure Proposed mechanisms of Staphylococcus aureus endocarditis. CVC, central venous catheter; IV, intravenous; S. ... Take home figure Proposed.

Fig. 1 Kaplan-Meier plot presenting no difference in progression to RA in patients with clinically suspect ... Fig. 1 Kaplan-Meier plot presenting no difference.

Figure 1. Oncoprint of selected pathogenic alterations detected in ctDNA. Unless provided in the caption above, the following copyright applies to the.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Figure 1 Patient selection

Figure 1 Effect of Ang II treatment for 4 weeks on aortic IL-12p35 expression. (A) IL-12p35 levels were measured in ... Figure 1 Effect of Ang II treatment.

Figure 1 Correlation between en face Oil-Red O staining and aortic root lesion size vs. plasma cholesterol and ... Figure 1 Correlation between en face.

Fig. 1 A network representation of top 100 co-occurring terms

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Fig. 1 Statistics of the main characters’ dialogues.

Figure 1 Patient selection.

Fig. 1 Query formulation process in CLIR

Figure 1. Longitudinal measures of HIV persistence and immunologic phenotype/function during anti-PD-1 therapy are ... Figure 1. Longitudinal measures.

Figure 1 Grant agencies and charitable foundations supporting Plan S.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Fig. 1 Schematic subcategorization of AAV in three clinically relevant disease categories defined by clinical ... Fig. 1 Schematic subcategorization of.

Figure 1 Strategies for reconciling protection and participation.

Figure 1 ABCDE of primary prevention.2

Figure 1. Forest plot of lung cancer mortality in LDCT trials.

Figure 1. Evolutionary process of a policy field.

Table 2. Mean noise level results for hand dryers in dBA

Presentation transcript:

Figure 1 Collagen is associated with ChemR23 expression in human and murine vascular smooth muscle cells. (A) Positive ... Figure 1 Collagen is associated with ChemR23 expression in human and murine vascular smooth muscle cells. (A) Positive association between ChemR23 and Col1A1 mRNA in human arteries (n = 60 patients; regression coefficient r = 0.538, P < 0.0001). (B) Mouse VSMC Col1A1 mRNA and protein expression after 24 h in culture. Data are represented as mean ± standard deviation of 3–5 independent experiments. *P < 0.05; **P < 0.01. Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2018. For permissions, please email: journals.permissions@oup.com.This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) Cardiovasc Res, cvy316, https://doi.org/10.1093/cvr/cvy316 The content of this slide may be subject to copyright: please see the slide notes for details.

Figure 2 ChemR23 deletion alters aortic smooth muscle cell phenotype in vitro. (A) mRNA expression of genes encoding ... Figure 2 ChemR23 deletion alters aortic smooth muscle cell phenotype in vitro. (A) mRNA expression of genes encoding contractile proteins after 24 h and 9 days in culture. (B) Aortic smooth muscle cell proliferation after 72 h measured by <sup>3</sup>H-thymidine incorporation (expressed in counts per minute, cpm). (C) mRNA expression of genes relevant for calcification. Data are represented as mean ± standard deviation of 3–8 independent experiments. *P < 0.05; **P < 0.01. Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2018. For permissions, please email: journals.permissions@oup.com.This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) Cardiovasc Res, cvy316, https://doi.org/10.1093/cvr/cvy316 The content of this slide may be subject to copyright: please see the slide notes for details.

Figure 3 ChemR23 deficient VSMCs exhibit reduced calcification and osteogenic signalling. (A) Quantification of ... Figure 3 ChemR23 deficient VSMCs exhibit reduced calcification and osteogenic signalling. (A) Quantification of phosphate-induced calcification after 9 days and representative images of alizarin red stained mouse aortic smooth muscle cells. (B) mRNA expression of genes involved in calcification in VSMCs after 9 days in culture under calcifying conditions. (C) Immunoblotting and immunofluorescence against phosphorylated SMAD 1/5/8 after 30 min stimulation with BMP-2 (D) mRNA expression and supernatant OPG protein levels. Quantification and representative images of phosphate-induced VSMC calcification after antibody mediated neutralization of OPG. Data are represented as mean ± standard deviation of 3–9 independent experiments. *P < 0.05; **P < 0.01. Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2018. For permissions, please email: journals.permissions@oup.com.This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) Cardiovasc Res, cvy316, https://doi.org/10.1093/cvr/cvy316 The content of this slide may be subject to copyright: please see the slide notes for details.

Figure 4 ChemR23 deletion protects from VitD3 induced vascular calcification in vivo. (A) Quantification of aortic ... Figure 4 ChemR23 deletion protects from VitD3 induced vascular calcification in vivo. (A) Quantification of aortic root calcification as a percentage of the alizarin red positive area within the total vessel area, and representative images of alizarin red and Von Kossa stained aortic roots. (B) Total Ca<sup>+2</sup> content in the right carotid artery. (C) Immunoblotting of the aorta against phosphorylated SMAD 1/5/8 (D) Bone mineral density of the right femur. (E) Aortic mRNA expression of smooth muscle cell markers. (F) Col1A1 immunohistochemistry quantification, and representative photomicrographs of the aortic root. (G) Aortic mRNA expression of genes involved in calcification promotion and inhibition. (H) Plasma OPG levels. (I) Plasma phosphate levels. Data are represented as mean ± standard deviation. ChemR23<sup>+/+</sup>n = 5, ChemR23<sup>−/−</sup>n = 6. *P < 0.05; **P < 0.01. Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2018. For permissions, please email: journals.permissions@oup.com.This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) Cardiovasc Res, cvy316, https://doi.org/10.1093/cvr/cvy316 The content of this slide may be subject to copyright: please see the slide notes for details.

Figure 5 Effects of resolvinE1 (RvE1) and (A) quantification of phosphate-induced calcification after 9 days and ... Figure 5 Effects of resolvinE1 (RvE1) and (A) quantification of phosphate-induced calcification after 9 days and representative images of alizarin red stained cells treated with either vehicle (Ethanol) or RvE1. (B) mRNA expression of VSMCs treated with RvE1 or vehicle for 9 days under calcifying conditions. Data are represented as mean ± standard deviation. *P < 0.05; **P < 0.01. Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2018. For permissions, please email: journals.permissions@oup.com.This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) Cardiovasc Res, cvy316, https://doi.org/10.1093/cvr/cvy316 The content of this slide may be subject to copyright: please see the slide notes for details.